These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 18507542

  • 1. Time course of effects of cardiac resynchronization therapy in chronic heart failure: benefits in patients with preserved exercise capacity.
    Piepoli MF, Villani GQ, Corrà U, Aschieri D, Rusticali G.
    Pacing Clin Electrophysiol; 2008 Jun; 31(6):701-8. PubMed ID: 18507542
    [Abstract] [Full Text] [Related]

  • 2. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T, Wolfel E, Feldman AM, Lowes B, Higginbotham MB, Ghali JK, Wagoner L, Kirlin PC, Kennett JD, Goel S, Saxon LA, Boehmer JP, Mann D, Galle E, Ecklund F, Yong P, Bristow MR.
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [Abstract] [Full Text] [Related]

  • 3. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K, Kedia N, Martin D, Tchou P, Natale A, Wilkoff B, Starling R, Grimm RA.
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M, Lunati M, Gasparini M, Santini M, Padeletti L, Achilli A, Bianchi S, Laurenzi F, Curnis A, Vincenti A, Valsecchi S, Denaro A, InSync/InSync ICD Italian Registry Investigators.
    Am J Cardiol; 2007 Sep 15; 100(6):1007-12. PubMed ID: 17826388
    [Abstract] [Full Text] [Related]

  • 5. Functional capacity and changes in the neurohormonal and cytokine status after long-term CRT in heart failure patients.
    Seifert M, Schlegl M, Hoersch W, Fleck E, Doelger A, Stockburger M, Butter C.
    Int J Cardiol; 2007 Sep 14; 121(1):68-73. PubMed ID: 17582527
    [Abstract] [Full Text] [Related]

  • 6. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T, Yoshida T, Hiraki T, Ohe M, Takeuchi T, Nagamoto Y, Fukuda Y, Gondo T, Imaizumi T.
    Europace; 2008 Mar 14; 10(3):379-83. PubMed ID: 18227354
    [Abstract] [Full Text] [Related]

  • 7. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.
    Lecoq G, Leclercq C, Leray E, Crocq C, Alonso C, de Place C, Mabo P, Daubert C.
    Eur Heart J; 2005 Jun 14; 26(11):1094-100. PubMed ID: 15728648
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mid-term outcomes of triple-site vs. conventional cardiac resynchronization therapy: a preliminary study.
    Lenarczyk R, Kowalski O, Kukulski T, Pruszkowska-Skrzep P, Sokal A, Szulik M, Zielińska T, Kowalczyk J, Pluta S, Sredniawa B, Musialik-Łydka A, Kalarus Z.
    Int J Cardiol; 2009 Mar 20; 133(1):87-94. PubMed ID: 18242737
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ.
    Am J Cardiol; 2007 Dec 01; 100(11):1665-70. PubMed ID: 18036366
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Three years of cardiac resynchronization therapy: could superior benefits be obtained in patients with heart failure and narrow QRS?
    Gasparini M, Regoli F, Galimberti P, Ceriotti C, Bonadies M, Mangiavacchi M, Andreuzzi B, Bragato R, Pini D, Klersy C, Gronda E.
    Pacing Clin Electrophysiol; 2007 Jan 01; 30 Suppl 1():S34-9. PubMed ID: 17302713
    [Abstract] [Full Text] [Related]

  • 13. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG, Hua W, Zhang S, Chu JM, Chen KP, Wang Y, Wang FZ, Chen X.
    Chin Med J (Engl); 2009 Mar 20; 122(6):617-21. PubMed ID: 19323922
    [Abstract] [Full Text] [Related]

  • 14. Effects of cardiac resynchronization therapy on heart rate turbulence.
    Sredniawa B, Lenarczyk R, Musialik-Lydka A, Kowalski O, Kowalczyk J, Cebula S, Sliwinska A, Szulik M, Kalarus Z.
    Pacing Clin Electrophysiol; 2009 Mar 20; 32 Suppl 1():S90-3. PubMed ID: 19250121
    [Abstract] [Full Text] [Related]

  • 15. Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.
    Steendijk P, Tulner SA, Bax JJ, Oemrawsingh PV, Bleeker GB, van Erven L, Putter H, Verwey HF, van der Wall EE, Schalij MJ.
    Circulation; 2006 Mar 14; 113(10):1295-304. PubMed ID: 16520415
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of cardiac resynchronization therapy in patients with end-stage heart failure.
    Molhoek SG, Bax JJ, Bleeker GB, Holman ER, Van Erven L, Bootsma M, Boersma E, Steendijk P, Van Der Wall EE, Schalij MJ.
    J Cardiovasc Electrophysiol; 2005 Jul 14; 16(7):701-7. PubMed ID: 16050826
    [Abstract] [Full Text] [Related]

  • 17. Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study.
    Lenarczyk R, Kowalski O, Kukulski T, Szulik M, Pruszkowska-Skrzep P, Zielinska T, Kowalczyk J, Pluta S, Duszanska A, Sredniawa B, Musialik-Lydka A, Kalarus Z.
    Europace; 2007 Sep 14; 9(9):762-7. PubMed ID: 17631515
    [Abstract] [Full Text] [Related]

  • 18. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE-ICD) trials.
    Pires LA, Abraham WT, Young JB, Johnson KM, MIRACLE and MIRACLE-ICD Investigators.
    Am Heart J; 2006 Apr 14; 151(4):837-43. PubMed ID: 16569543
    [Abstract] [Full Text] [Related]

  • 19. Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
    Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P, van der Wall EE, Schalij MJ.
    Am J Cardiol; 2004 Apr 01; 93(7):860-3. PubMed ID: 15050489
    [Abstract] [Full Text] [Related]

  • 20. Effect of right ventricular lead location on response to cardiac resynchronization therapy in patients with end-stage heart failure.
    Haghjoo M, Bonakdar HR, Jorat MV, Fazelifar AF, Alizadeh A, Ojaghi-Haghjghi Z, Esmaielzadeh M, Sadr-Ameli MA.
    Europace; 2009 Mar 01; 11(3):356-63. PubMed ID: 19136489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.